A prospective exploratory clinical study of penpulimab plus anlotinib as first-line treatment for locally advanced or metastatic urothelial carcinoma.

被引：0
|
作者：
Yang, Bo
Xiong, Qi
Song, Qi
Long, Yaping
Guo, Gang
Li, Hongzhao
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, First Med Ctr, Dept Oncol, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China
[4] Med Ethics Comm Chinese PLA Gen Hosp, Beijing, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, First Med Ctr, Dept Urol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4567
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-line Immunotherapy in Metastatic Urothelial Carcinoma
    Ghatalia, Pooja
    Zibelman, Matthew
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 45 - 47
  • [22] Tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma
    Yoon, Harry H.
    Kato, Ken
    Hubner, Richard
    Raymond, Eric
    Tao, Aiyang
    Liu, Sumei
    Qazi, Ibrahim
    Xu, Jian-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [23] Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase 2 study.
    Du, Juan
    Tong, Fan
    Sha, Hui-zi
    Sun, Yi
    Zhu, Yahui
    Qi, Liang
    Li, Xiaoqin
    Li, Wei
    Yang, Yan
    Li, Zeqing
    Xu, Caihua
    Ni, Jiayao
    Gu, Qing
    Zhang, Xing
    Zhu, Chan
    Wang, Xiaoxuan
    Liu, Baorui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
  • [25] Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yilmaz, Ugur
    Bilgetekin, Irem
    Yildiz, Birol
    Sendur, Mehmet Ali Nahit
    Erman, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [26] Camrelizumab plus apatinib combined with TACE and cryoablation in the first-line treatment of advanced hepatocellular carcinoma.
    Xing, Wenge
    Guo, Zhi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft-tissue sarcoma: Updated results.
    Li, Tao
    Ye, Zhaoming
    Wei, Yongzhong
    Wang, Shoufeng
    Liu, Yunxia
    Chen, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
    Tassinari, Elisa
    Mollica, Veronica
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Massari, Francesco
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1945 - 1960
  • [29] Medical oncologists' first-line treatment preferences in metastatic urothelial carcinoma
    Apolo, Andrea B.
    Cambron-Mellott, M. Janelle
    Beusterien, Kathleen
    Seal, Brian S.
    Maculaitis, Martine C.
    Bernstein, Andrew
    Epperson, Megan
    Jeffress, Mara Lisa
    Doleh, Yunes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [30] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    E. El Rassy
    T. Assi
    Z. Bakouny
    N. Pavlidis
    J. Kattan
    Clinical and Translational Oncology, 2019, 21 : 280 - 288
12345